PharMEDium Recalls Potassium Chloride Injection Due to Labeling Error
PharMEDium Services recalls 240 bags of Potassium Chloride added to 5% Dextrose Injection due to mislabeling. Check lot numbers and expiration dates.
Use caution until it’s fixed
Labeling: Not Elsewhere Classified: Potassium Chloride was printed on Potassium Phosphate label stock thereby having both names on the label of a 250 mL bag of Potassium Chloride.
Contact the company
What happened, in plain English
PharMEDium Services, LLC is recalling a small quantity of Potassium Chloride added to 5% Dextrose Injection because the product label was printed on Potassium Phosphate stock. This error means the bag displays both Potassium Chloride and Potassium Phosphate names, creating a risk of medication error. The recall affects 240 bags distributed in New York. Read more at govinfonow.com/recall/42667-pharmedium-recalls-potassium-chloride-injection-due-to-labeling-error.
Source Summary by GovInfoNow · govinfonow.com/recall/42667-pharmedium-recalls-potassium-chloride-injection-due-to-labeling-error · Updated October 9, 2026 · FDA enforcement record: FDA #D-0976-2016
Cite this page
“PharMEDium Recalls Potassium Chloride Injection Due to Labeling Error.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42667-pharmedium-recalls-potassium-chloride-injection-due-to-labeling-error. Based on FDA recall #D-0976-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0976-2016%22&limit=1).
Why it’s dangerous
The primary hazard is a labeling error where Potassium Chloride was printed on label stock intended for Potassium Phosphate. This dual-naming on the label could lead healthcare professionals to confuse the drug's identity or composition, potentially resulting in the administration of the wrong electrolyte therapy.
Who’s affected
Healthcare providers and patients in New York who received the specific lot of this intravenous solution are affected. Patients relying on this specific formulation for potassium supplementation are at risk of receiving incorrect medication information.
How to tell if you have this one
Look for PharMEDium Services, LLC Potassium CHLORide added to 5% Dextrose Injection, 20 mEq 250 mL Bag. Specifically check for NDC 61553-836-11, Service Code 2K5836, and Lot# 161300033M with an expiration date of 07/26/16.
- Brand
PharMEDium Services- Category
Drug
What to do — step by step
Verify Product Details
Check your inventory for NDC 61553-836-11, Service Code 2K5836, Lot# 161300033M, Exp 07/26/16.
Contact Manufacturer
Since the remedy is not stated in the record, contact PharMEDium Services directly for instructions on how to handle these bags.
Where it went and when
Where it was distributed
Distributed in New York.
FDA distribution: “NY” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: New York.
Recall timeline
FDA terminated this recall 37 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0976-2016 (May 16, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0976-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.